Boston Scientific Corporation
BSX has entered into a definitive agreement to acquire privately-held
Rhythmia Medical, Inc., a developer of next-generation mapping and navigation
solutions for use in cardiac catheter ablations and other electrophysiology
procedures, including atrial fibrillation and atrial flutter. Rhythmia
Medical is based in Burlington, MA. The transaction is expected to close by
Friday, October 12^th.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in